The Chinese Journal of Interventional Cardiology is supervised by the Ministry of Education of the People's Republic of China and hosted by Peking University. It is an academic journal in the cardiovascular field, distributed domestically and internationally on a monthly basis. The target readers of this journal are cardiovascular clinical and research professionals, especially those in interventional cardiology. The editorial philosophy of the journal is to implement the health policies of the Party and the country, combining theory with practice, promoting improvement and popularization, and advocating for diverse opinions and discussions. The journal publishes clinical and basic research articles on interventional diagnosis and treatment based on catheterization techniques, as well as introducing the latest domestic and international advancements, diagnostic and treatment methods, and prevention experiences. It includes sections on guidelines and consensus, clinical research, basic research, reviews, expert discussions, interpretation of guidelines and consensus, meeting summaries, international academic exchanges, continuing education, difficult case analyses, case reports, new technological methods, clinical experience sharing, and reviews, welcoming active submissions.

1. Submission Requirements and Notes

1.1 Manuscript Requirements

Manuscripts should have a clear theme, reasonable design, rigorous logic, reliable data, smooth writing, and be innovative, scientific, directional, and practical. When reporting experiments involving human subjects, authors should specify: (1) whether the procedures followed comply with the medical ethics standards set by the ethics committee (institution, region, country) responsible for human experiments and have obtained approval from that committee; (2) whether informed consent was obtained from the subjects or their relatives. For animal studies, researchers should conduct experiments humanely and strictly adhere to ethical regulations for animal experiments.

1.2 Submission

The 'Chinese Journal of Interventional Cardiology' only accepts online submissions. Please register and submit online at http://zjxb.cbpt.cnki.net/. After initial review, authors are required to pay a review fee of 150 RMB [the journal follows a three-review system based on peer review (double-blind review system)]. Authors can check the status of their manuscript online and download the 'Author Contribution Declaration,' 'Author Conflict of Interest Disclosure,' and 'Introduction Letter and Authorization Form for Submission to the Chinese Journal of Interventional Cardiology.' Submissions should include these three documents to verify the authenticity of the content, single submission, no confidentiality issues, and undisputed authorship. When the paper involves work conducted abroad, proof of consent from the relevant foreign entity or individual for publication in this journal should be provided. Papers funded by grants or research projects should include a copy of the funding approval. If there is a clinical trial registration number, please provide it.

Contact Address: Chinese Journal of Interventional Cardiology Company, No. 10-3, Yard 25, Jinghai Fourth Road, Economic and Technological Development Zone, Yizhuang, Beijing 100023

Phone: 010-57730142 / 15313834668

1.3 Express Lane

The journal has established a 'Express Lane' for innovative research results of international leading level or papers reporting international firsts. Authors requesting publication through the 'Express Lane' should provide an explanation of the paper's innovation (along with two expert review forms from different institutions) and a plagiarism report. Eligible manuscripts will undergo a rapid review process for timely publication.

1.4 Manuscript Handling

The journal follows a strict expert review system and selects manuscripts based on academic quality in a fair and objective manner. If authors do not receive a notification regarding the handling of their submission within 3 months of receiving the journal's acknowledgment of receipt, it indicates that the manuscript is still under review. Authors wishing to submit to another journal should contact the editorial office first and avoid submitting the same manuscript to multiple sources. If duplicate submission is discovered, the manuscript will be immediately rejected; if dual use is found, the journal will publish a statement declaring the repeated publication of the article and reject any future submissions from the author as the first author for two years. Authors of rejected manuscripts are allowed to submit written appeals regarding the rejection. The journal does not encourage the republication of manuscripts in different languages. Authors are responsible for the authenticity and scientific quality of their submissions. In accordance with the Copyright Law of the People's Republic of China, the journal may make textual modifications, deletions, and technical edits to submissions. Any modifications that affect the original intent will be discussed with the authors. Manuscripts that are not revised within 2 months will be considered withdrawn automatically.

1.5 Paper Authorization

Upon acceptance for publication, all authors must personally sign the 'Introduction Letter and Authorization Form for Submission to the Chinese Journal of Interventional Cardiology,' 'Author Contribution Declaration,' and 'Author Conflict of Interest Disclosure,' granting exclusive use rights of the paper to the Chinese Journal of Interventional Cardiology. Within the authorized period, the journal has the right to publish the paper in print, electronic, CD, app, WeChat, and other formats, and has the rights to reproduce, translate, distribute, and include the paper in literature retrieval systems or databases, with worldwide coverage. Without the consent of the Chinese Journal of Interventional Cardiology, no part of the paper may be reprinted elsewhere.

1.6 Fees

After confirmation of publication, authors are required to pay the relevant publication fees as notified. Additional fees are required for color illustrations. Authors (unless otherwise specified, such as special issues for conferences) will receive remuneration after publication (including other forms of publication remuneration) and two complimentary copies of the current issue.